Skip to content

APOTENA

Active Public limited companyfounded 2006active for 19 yearsBeemdstraat 2, 1601 Sint-Pieters-LeeuwKBO/BCE: BE 0885.774.405 subsidiary of

Lifetime

19 annual accounts with figures on one time axis
peak €1.0m (2025)
€1.0m▲ 2.1%
lowest -€3,161 (2014)
€415,608▲ 21.4%
peak €711,907 (2025)
€711,907unchanged
€1.2m▼ 9.4%
peak 7.6 FTE (2025)
7.6 FTE▲ 7.0%
Board5 names since 2015
- 
Owners2 names in the annual accounts
100%
Documentsfilings and deeds
24-07-20267 days before the deadline
2025abbreviated format
A quiet year: no large shift against the year before.

Key points

from the 2025 annual accounts

Equity

€711,907 =

APOTENA has made a profit without a break since 2015.

Turnover

≈ €2.7m estimated

The abbreviated format states no turnover.

Staff

10 employees on 31-12-2025
54202124202215132023542024452025

In 2025, 4 people joined and 5 left.

Filings

19 annual accounts since 2007
AprilJune31 JulyOctober2010201520202025

Three of the last ten came late. The 2022 accounts came latest: 58 days after the end of the period.

Position in the sector

€415,608

Higher net result than 95% of companies in retail trade. Sector median €38,004 · 13,251 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,721 companies had the same profile as APOTENA has now. Each dot stands for 87 companies, two years later.

95.3%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,721 companies, not a prediction for APOTENA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

last known board
Director, until 2024
Managing director, until 2024
Director, until 2024
  • 100%score equity €1.4m (2025) · 2025 annual accounts of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0885774405
Registered office moved to Ruisbroek New registered office: Beemdstraat 2 bus 1, 1601 Ruisbroek · Change of role: , from director to sole director · Resignations: (director) and (director) · General meeting of 08-11-2024 · Gazette deed
Board meeting of 24-11-2022 Gazette deed
3 directors reappointed , and · General meeting of 07-06-2021 · Gazette deed
All 32 events

Comparable companies

same main activity, similar in size and age
Company
APOTENA Sint-Pieters-Leeuw €1.9m €1.0m 38.2% 7.6
Geassocieerde Apotheek Schoten Schoten €1.9m €1.0m 59.8% 8.7
PHARMACCUEIL Limbourg €2.0m €0.8m 23.5% 8
DE LUCHTHAVEN APOTHEEK Zaventem €1.5m €0.8m 46.5% 6.1
Apotheek Roos Ghent €1.5m €0.8m 62.3% 6.9
PHARMACIE RENARD Ciney €1.5m €0.8m 76.6% 8
KRISTOF BEHEYT Maldegem €2.3m €1.4m 10.1% 8.6

These companies have the same main activity as APOTENA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.5m and €2.3m, founded between 2003 and 2008.

Official details

Source: KBO
Status
Active since 19-12-2006Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 5 others
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment units
2.159.098.7491600 Sint-Pieters-Leeuw, since 22-01-2007
2.241.855.8821601 Sint-Pieters-Leeuw, since 01-01-2015
Financial year end
31 December
Peppol
Reachable since 26-02-2025
Company details

Annual accounts 2025

€1.9m▼ 6.0%
Employeeson 31-12-2025
10▼ 9.1%
Filing
Filed on 24-07-2026, 7 days before the end of the filing period
Financials

Insights on APOTENA

APOTENA files the abbreviated format. That format states no turnover. The gross margin rose from €264,117 in 2007 to €1.0m in 2025.

holds all the shares. In November 2024, three directors stepped down.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTENA

What is the company number of APOTENA?
The company number of APOTENA is 0885.774.405. The VAT number is the same number with BE in front: BE 0885.774.405.
Where is APOTENA based?
The registered office is at Beemdstraat 2, 1601 Sint-Pieters-Leeuw.Company details
What does APOTENA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTENA?
APOTENA is a public limited company (NV).
When was APOTENA founded?
APOTENA was founded on 19-12-2006.
Is APOTENA still active?
Yes, APOTENA is an active enterprise in the KBO register.
How many employees does APOTENA have?
APOTENA had an average of 7.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTENA fall under?
In its 2025 annual accounts, APOTENA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTENA?
The turnover in financial year 2025 is ≈ €2.7m. This figure is estimated from the gross margin of €1.0m and 31 comparable companies (NACE 477). It probably lies between €2.0m and €3.8m.
Is APOTENA profitable?
In financial year 2025, APOTENA made a profit of €415,608.
Where can I find the annual accounts of APOTENA?
APOTENA filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTENA due?
APOTENA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.